Before a treatment decision
What to check before treatment
Clear answers about the product and its label matter as much as the name of the treatment. Keep the questions specific.
Start with the label and the source
The Ohio pharmacy board says products marked “For Research Only” or “RUO” must not be administered as treatment, as of September 28, 2026. Ohio’s patient cautions
RUO is shorthand for research use only.
FDA is the Food and Drug Administration.
A government drug list identifies a product with a National Drug Code (NDC) number. If a label or an offer shows an NDC number, that is not proof of FDA approval, says the FDA (as of September 26, 2026). FDA on NDC numbers
- Ask who made the medicine and which pharmacy gave or sent it to you.
- Match the pharmacy name to the Ohio record.
- Ask about any unclear product name or label.
Have unclear instructions explained
FDA has received reports of harm, sometimes involving hospital care, after dose errors with compounded semaglutide (checked September 26, 2026). FDA’s report on medicine errors
- Ask the prescriber or pharmacist to explain the label in ordinary words.
- Bring up pregnancy, plans for pregnancy or breastfeeding during the visit.
- Ask which symptoms call for a prompt call or urgent help.
Compounded products do not have the same FDA-reviewed pregnancy information as approved products, based on FDA information checked September 17, 2026. FDA on the review gap
Storage is specific to the product
Some peptide medicines need cooling and others are kept at room temperature; the exact product’s label matters (checked September 17, 2026). NIH’s room-temperature medicine label
NIH’s semaglutide storage information
FDA advises against using an injectable semaglutide or tirzepatide product that arrives warm or without enough cooling, as of September 17, 2026. FDA on delivery and cooling
- Ask the pharmacist how the exact product is stored.
- Ask how to report a delivery that does not match those instructions.
Severe symptoms need urgent help
MedlinePlus information checked September 17, 2026, classifies a severe allergic reaction as an emergency requiring medical care.
It advises emergency help for severe symptoms, which can include breathing trouble or swelling of the tongue. MedlinePlus on severe allergic reactions
- Seek emergency care for severe symptoms.
- Tell the treating clinician what medicine was involved.
A patient can report a medicine problem
FDA’s MedWatch accepts reports from both patients and health professionals, as of September 17, 2026. Open FDA’s MedWatch information
A report does not prove a medicine caused the problem, according to FDA information checked September 17, 2026.
- Keep the label and notes about what happened.
- Use the right Ohio board for a complaint about care.